Skip to main content
Journal Article

Short acting beta2-agonists for bronchiectasis

  • Franco F
  • Sheikh A
  • Greenstone M
Cochrane Database of Systematic Reviews (2003)
DOI: 10.1002/14651858.cd003572
46Citations
Citations of this article
82Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We failed to identify any RCTs investigating the role of short acting beta agonists in bronchiectasis. Since short acting beta-2 agonist therapy is the most frequently used treatment for airflow obstruction in bronchiectasis, there appears to be the need to investigate the effectiveness of this therapy using an RCT.

Cite

CITATION STYLE

APA

Franco, F., Sheikh, A., & Greenstone, M. (2003). Short acting beta2-agonists for bronchiectasis. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd003572

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free